BSE NSE
Your Result on : Company News
Alivus Life Sciences Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
543322
ISIN Demat
INE03Q201024
Book Value (Rs)
229.7492749
NSE Symbol
ALIVUS
Divident Yield %
0.5
Market Cap
(Rs In Cr.)
12,278
P/E (TTM)
25.28
EPS (TTM)
39.6
Face Value
(Rs)
2
Date Heading
24-Jun-25 Alivus Life Sciences Ltd - Alivus Life Sciences Limited - Copy of News
24-Jun-25 Alivus Life Sciences Ltd - Alivus Life Sciences Limited - Copy of News
09-Jun-25 Alivus Life Sciences Ltd - Alivus Life Sciences Limited - Analysts/Ins
02-Jun-25 Alivus Life Sciences Ltd - Alivus Life Sciences Limited - Analysts/Ins
30-May-25 Alivus Life Sciences Ltd - Alivus Life Sciences Limited - Updates
26-May-25 Alivus Life Sciences Ltd - Alivus Life Sciences Limited - Analysts/Ins
23-May-25 Alivus Life Sciences Ltd - Alivus Life Sciences Limited - Analysts/Ins
16-May-25 Board of Alivus Life Sciences recommends final dividend
16-May-25 Alivus Life Sciences standalone net profit rises 44.85% in the March 2
16-May-25 Alivus Life Sciences Ltd - Glenmark Life Sciences Limited - Dividend
16-May-25 Alivus Life Sciences Ltd - Alivus Life Sciences Limited - Analysts/Ins
09-May-25 Alivus Life Sciences to hold board meeting
09-May-25 Alivus Life Sciences Ltd - Glenmark Life Sciences Limited - Board Meet
02-May-25 Alivus Life Sciences Ltd - Glenmark Life Sciences Limited - Other Gene
30-Apr-25 Alivus Life Sciences allots 92,096 equity shares under ESOS
Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, developed & powered by C-MOTS Infotech (ISO 9001:2015 certified)